Rotterdam, Netherlands

Ermond Reijer Van Beek

This inventor holds 4 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Gador S.a., Hq Medical Netherlands B.v., Publiekrechtelijk Rechtspersoon Academisch Ziekenhuis Leiden H.o.d.n. Lumc. Active years: 1999-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ermond Reijer Van Beek. Retrieved from https://idiyas.com/inventor/ermond-reijer-van-beek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Leiden, NL (1999)
  • Rotterdam, NL (2020)

Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Ermond Reijer Van Beek: Innovator in Cell Death Detection and Cancer Therapy

Introduction

Ermond Reijer Van Beek is a notable inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of biomedical research, particularly in the detection of cell death and the development of therapies for cancer. With a total of 4 patents, his work has the potential to impact various medical applications.

Latest Patents

One of his latest patents is related to a protein target complex. This invention involves a method for labeling or targeting cells whose plasma membrane has lost integrity, such as dead cells. The method is designed to discriminate between live cells and those that have lost membrane integrity. It can be utilized in assays for screening drugs for therapies, including cancer therapy, and for monitoring the effectiveness of such therapies. Additionally, it encompasses an assay kit and a complex for use as a medicament in treating cancers and supporting the immune system.

Another significant patent is the cell death assay, which describes a method for detecting cell death using a luminescent compound. This method is versatile and applicable for detecting cell death regardless of the mechanism involved, whether it be apoptosis or necrosis. The patent also includes luminescent compounds for specific uses and a kit comprising these compounds.

Career Highlights

Throughout his career, Ermond Reijer Van Beek has worked with various organizations, including Hq Medical Netherlands B.V. His innovative approaches and research have positioned him as a key figure in the field of medical technology.

Collaborations

He has collaborated with notable individuals such as Markwin Hendrik Maring and Clemens Waltherus Gerardus Löwik. These collaborations have further enriched his research and development efforts.

Conclusion

Ermond Reijer Van Beek's contributions to the field of cell death detection and cancer therapy through his patents demonstrate his commitment to advancing medical science. His work continues to pave the way for innovative solutions in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…